Compositions and methods for treatment of mitochondrial diseases
CA 2931872 C · Owner: Wellstat Therapeutics Corporation · Inventors: Von Borstel, Reid W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds, compositions and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidien nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 31, 1999 and granted August 6, 2019. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 31, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 31, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.